Female sex hormone clue to fighting serious immune diseaseJune 10, 2016
London, United Kingdom, June 10, 2016: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed for the first time a beneficial effect of oestrogens in experimental models of skin fibrosis that are representative of the disease process in systemic sclerosis (SSc). These findings may explain the increased incidence of SSc in women after the menopause, the greater severity of SSc in men, and importantly open up the possibility of developing potential hormone therapies for this difficult-to-treat condition.
SSc (also known as scleroderma) is an autoimmune disease affecting multiple organs, which predominantly affects women (with a female-to-male ratio of up to 9:1). Skin thickening is a defining feature of SSc, with excessive production of proteins such as collagen by fibroblasts resulting in skin thickening.
Skin involvement may be mainly confined to the face and extremities; however, in some SSc patients, disease progression is very rapid, with skin thickening extending beyond the extremities, and earlier, more widespread fibrosis involving the internal organs. The extent of skin involvement in SSc correlates inversely with survival and is considered a valuable marker of overall disease severity.3 Currently, no therapy with an acceptable toxicity profile has proven to be effective in the treatment of SSc skin disease.
"Because of the clear sex bias in SSc, we decided to assess if blocking the action of oestrogens, (female hormones that decrease in menopause) plays a role in the development or vulnerability to this disease," explained Dr Jerome Avouac of the Paris Descartes University, Cochin Hospital, Paris, France.
The effect of oestrogen inhibition was evaluated in mouse models of skin fibrosis using two techniques. Firstly, in a population of mice in whom gene inactivation had knocked out the key receptor that responds to oestrogens, and secondly using tamoxifen which is a hormone therapy that blocks the action of oestrogen. Results showed that oestrogen inhibition consistently and significantly exacerbated the process of skin fibrosis.
In a second experiment, skin fibroblasts from SSc patients were stimulated with the cytokine that activates skin fibrosis (TGF-β) and then incubated with different concentrations of 17-?-oestradiol (a form of oestrogen) and/or tamoxifen to inhibit oestrogen. Measurements of the release of collagen from the fibroblasts, differentiation of these fibroblasts into myofibroblasts, and evidence of activation of the TGF-β pathway all confirmed that oestrogens significantly slow down fibrosis.
"Having confirmed that oestrogens indeed play a role in protecting against skin fibrosis in experimental models representative of SSc, the next step will be to begin investigating the potential role of hormone therapies as a treatment of SSc skin disease," Dr Avouac concluded.
Abstract Number: OP0304
For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress
Press Office in the London Suite at ExCel London during EULAR 2016 or on:
Onsite tel: +44 (0) 7725 915 492 / +44 (0) 7786 171 476
Youtube: Eular Pressoffice
The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with Rheumatic Musculoskeletal Diseases (RMD) throughout Europe.
EULAR aims to promote, stimulate and support the research, prevention, and treatment of RMD and the rehabilitation of those it affects.
EULAR underlines the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs. EULAR is supported in this mission by its 45 scientific member societies, 36 PARE (People with Arthritis/Rheumatism in Europe) organisations, 22 HPR (Health Professionals in Rheumatology) associations and 23 corporate members.
The EULAR Annual European Congress of Rheumatology is the foremost international medical meeting announcing the latest research on rheumatic and musculoskeletal diseases. EULAR 2016 is expected to attract over 14,000 delegates from around 120 countries. Most if not all professions working in the vast field of RMD will be represented.
To find out more about the activities of EULAR, visit: http://www.eular.org
1. EULAR 2016; London: Abstract OP0304
2. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med. 2009, 360: 1989-2003
3. Krieg T, Takehara K: Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). 2009, 48: iii14-iii18
4. Postlethwaite AE, Harris LJ, Raza SH, Kodura S, Akhigbe T: Pharmacotherapy of systemic sclerosis. Expert Opin Pharmacother. 2010, 11: 789-806
European League Against Rheumatism
Related Fibroblasts Articles:
Estrogens act as a driving force of both healthy and cancerous mammary cell growth by binding to receptors that include GPER, which is generally located in cell membranes.
Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the behavior of fibroblast cells and the extracellular matrix.
New research findings published in the Journal of Leukocyte Biology, suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients.
Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), together with collaborators in Europe, discovered that a common type of cell within the human reproductive and intestinal tracts assists HIV in infecting immune cells.
A study led by researchers at the University of Birmingham reveals the key role of different types of fibroblast cells in the development of rheumatoid arthritis, opening up a new avenue for research into treatment of the disease.
Conventional, high-dose chemotherapy treatments can cause the fibroblast cells surrounding tumors to secrete proteins that promote the tumors' recurrence in more aggressive forms, researchers have discovered.
A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy.
Connective tissue cells in the heart turn into bone-producing cells in response to injury, UCLA scientists report Nov.
A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions.
In reading, a bookmark tells where you stopped. Cells use bookmarks too, specific proteins to help remember what collection of genes needs to be turned on again after cell division.
Related Fibroblasts Reading:
Fibroblast Growth Factors
by Xiaokun Li (Author)
Fibroblast Growth Factors presents research and results from the leading global research group on FGF, providing up-to-date and comprehensive coverage of the field. The book describes the history, basic research and growth engineering technology involved with FGFs, while also introducing detailed research methods. It comprises eight chapters that detail successes and problems in relation to wound healing of engineered growth factors and considers injury repair and regeneration, non-mitogenic mutants, structure modification, pathology, physiology, pharmacology, development, FGF/FGFR... View Details
Fibroblast Growth Factors: Biology and Clinical Application: FGF Biology and Therapeutics
by Michael Simons (Author)
The fibroblast growth factor (FGF) family of ligands and the corresponding family of FGF receptor tyrosine kinases comprise one of the most versatile and diverse growth factor signaling families in vertebrates, found virtually in every tissue and cell type where they regulate metabolic and physiologic function, maintain tissue homeostasis, and mediate injury response, tissue repair, and regeneration. As a result, FGFs play critical roles in a wide variety of normal biological and abnormalities in FGF signaling can lead to a variety of disease states from developmental malformations, to... View Details
Tumor-Associated Fibroblasts and their Matrix (The Tumor Microenvironment)
by Margareta M. Mueller (Editor), Norbert E. Fusenig (Editor)
During the last 20 years it has become increasingly clear that the tumor micro-environment, the tumor stroma with its cellular end extracellular components, plays an crucial role in regulating tumor growth and progression. This book on “Tumor-associated fibroblasts and their matrix” as part of the series on “Tumor-Microenvironment” is the first comprehensive discussion of these two main players of the tumor microenvironment. The best experts in this new area of tumor research and therapy review the role of these major components in the tumor stroma in the process of tumor development... View Details
Fibroblasts: Webster's Facts and Phrases
by Icon Group International (Author)
Ever need a fact or quotation on "fibroblasts"? Designed for speechwriters, journalists, writers, researchers, students, professors, teachers, historians, academics, scrapbookers, trivia buffs and word lovers, this is the largest book ever created for this word. It represents a compilation of "single sentences" and/or "short paragraphs" from a variety of sources with a linguistic emphasis on anything relating to the term "fibroblasts," including non-conventional usage and alternative meanings which capture ambiguities. This is not an encyclopedic book, but rather a collage of statements made... View Details
The Fibroblast growth factor family (Annals of the New York Academy of Sciences)
by ANDREW & MICHAEL KLAGSBRUN (eds.) BAIRD (Author)
Book by Andrew Baird View Details
Fibroblast-derived matrix: Regulation of type I collagen synthesis: Recreating the in vivo micro-environment
by Kevin Dzobo (Author)
Three dimensional cultures of cells have been used extensively to study cell-matrix interactions. These have included the use of hydrogels, sponges and mixtures of reconstituted matrix proteins such as laminin and fibronectin. The use of artificial matrices consisting of purified matrix proteins does not truly reflect the in vivo micro-environments that contain many other proteins mixed in a defined ratio. A novel in vitro model in use of late involves the use of a natural, cell-derived 3-D matrix that closely mimics the native tissue. As illustrated in this work, which investigated the... View Details
Fibroblast-like: Webster's Timeline History, 1957 - 2007
by Icon Group International (Author)
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Fibroblast-like," including when used in literature (e.g. all authors that might have Fibroblast-like in their name). As such, this book represents the largest compilation of timeline events associated with Fibroblast-like when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and... View Details
Fibroblast Growth Factor: Methods and Protocols (Methods in Molecular Medicine)
by Anthony Ashton (Author)
Fibroblast Growth Factor-23 as Novel Marker of Phosphate Homeostasis
by Noreen Abbas (Author), Aysha Habib Khan (Author)
Fibroblast growth factor 23 (FGF-23), is recently discovered phosphaturic substance. It releases from bone osteocytes and plays a key role in the physiological regulation of phosphate metabolism. Excessive action of FGF23 results in several hypophosphatemic diseases characterized by impaired renal tubular phosphate reabsorption. In contrast, deficient action of FGF23 causes familial hyperphosphatemic tumoral calcinosis with enhanced renal tubular phosphate reabsorption. We carried out this study to gain knowledge about the current status of FGF-23 levels in our population and its relationship... View Details
DNA double-strand break repair is impaired in presenescent Syrian hamster fibroblasts
by Bandirma Press (Author)
This open access article by various authors presents key research on DNA double-strand break repair is impaired in presenescent Syrian hamster fibroblasts. Studies of DNA damage response are critical for the comprehensive understanding of age-related changes in cells, tissues and organisms. Syrian hamster cells halt proliferation and become presenescent after several passages in standard conditions of cultivation due to what is known as culture stress. Using proliferating young and non-dividing presenescent cells in primary cultures of Syrian hamster fibroblasts, we defined their response to... View Details